Depressive Disorders - GCC | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$251.40m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.66%, resulting in a market volume of US$259.80m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$73.40 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in GCC is experiencing significant growth due to several factors. Customer preferences for mental health treatment, increasing awareness of depressive disorders, and the availability of advanced treatment options are driving this growth. Additionally, local special circumstances and underlying macroeconomic factors are contributing to the development of the market.Customer preferences in the GCC region are shifting towards seeking professional help for mental health issues, including depressive disorders. In the past, mental health was often stigmatized, leading individuals to avoid seeking treatment. However, there has been a significant shift in attitudes towards mental health, with more people recognizing the importance of seeking help for their emotional well-being. This change in customer preferences has created a growing demand for mental health services, including treatment for depressive disorders.One of the key trends in the Depressive Disorders market in the GCC is the increasing awareness of depressive disorders. As mental health education and awareness campaigns become more prevalent, individuals are becoming more informed about the signs and symptoms of depressive disorders. This increased awareness is leading to earlier diagnosis and treatment, resulting in a higher demand for services in the market.The market is also experiencing growth due to the availability of advanced treatment options for depressive disorders. Medical advancements, such as new medications and therapies, have improved the outcomes for individuals with depressive disorders. These advancements have not only increased the effectiveness of treatment but have also reduced the stigma associated with seeking help. As a result, more individuals are willing to seek treatment and are benefiting from the available options.In addition to customer preferences and global trends, there are also local special circumstances that are contributing to the development of the Depressive Disorders market in the GCC. The region has a high prevalence of depressive disorders, which can be attributed to various factors such as stress, lifestyle changes, and cultural norms. These local circumstances have created a significant demand for mental health services, driving the growth of the market.Underlying macroeconomic factors, such as population growth and economic development, are also contributing to the development of the market. The GCC region has experienced rapid population growth in recent years, resulting in an increased demand for healthcare services. Additionally, economic development has led to an improvement in living standards and increased healthcare spending, further fueling the growth of the Depressive Disorders market.In conclusion, the Depressive Disorders market in the GCC is experiencing significant growth due to customer preferences, increasing awareness, advanced treatment options, local special circumstances, and underlying macroeconomic factors. As the region continues to prioritize mental health and invest in healthcare infrastructure, the market is expected to further develop in the coming years.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.